Axsome Therapeutics Inc
NASDAQ:AXSM
Axsome Therapeutics Inc
NASDAQ:AXSM
Price:
188.99
USD
2.61%
Market Closed
Market Cap:
$9.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Axsome Therapeutics Inc
NASDAQ:AXSM
|
US |
|
Rush Street Interactive Inc
NYSE:RSI
|
US |
|
G
|
Guangdong CHJ Industry Co Ltd
SZSE:002345
|
CN |
|
Seoyon Co Ltd
KRX:007860
|
KR |
|
C
|
Craneware PLC
OTC:CRWRF
|
UK |
|
Winmark Corp
NASDAQ:WINA
|
US |
Balance Sheet
Balance Sheet Decomposition
Axsome Therapeutics Inc
Axsome Therapeutics Inc
Balance Sheet Decomposition is not available for
Axsome Therapeutics Inc
Axsome Therapeutics Inc
Balance Sheet
Axsome Therapeutics Inc
Axsome Therapeutics Inc
Currency: USD
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
2
|
3
|
48
|
37
|
34
|
14
|
220
|
184
|
87
|
201
|
386
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
14
|
220
|
184
|
87
|
0
|
0
|
0
|
|
| Cash Equivalents |
2
|
3
|
48
|
37
|
34
|
0
|
0
|
0
|
0
|
201
|
386
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
95
|
142
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
38
|
95
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
15
|
16
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
3
|
8
|
12
|
|
| Total Current Assets |
2
|
3
|
49
|
38
|
35
|
15
|
220
|
184
|
87
|
246
|
504
|
485
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
8
|
6
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
60
|
53
|
47
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
12
|
12
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
11
|
19
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
12
|
12
|
|
| Total Assets |
2
N/A
|
3
+33%
|
49
+1 654%
|
38
-22%
|
36
-7%
|
15
-57%
|
221
+1 332%
|
186
-16%
|
88
-53%
|
332
+278%
|
588
+77%
|
568
-3%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
0
|
1
|
2
|
4
|
3
|
4
|
11
|
14
|
13
|
39
|
41
|
72
|
|
| Accrued Liabilities |
0
|
0
|
1
|
3
|
3
|
4
|
11
|
10
|
10
|
52
|
92
|
147
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
0
|
0
|
0
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
6
|
6
|
9
|
|
| Total Current Liabilities |
4
|
1
|
3
|
7
|
12
|
11
|
25
|
23
|
23
|
97
|
139
|
230
|
|
| Long-Term Debt |
0
|
4
|
0
|
10
|
7
|
4
|
17
|
48
|
49
|
94
|
178
|
184
|
|
| Other Liabilities |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
31
|
80
|
98
|
|
| Total Liabilities |
4
N/A
|
6
+46%
|
3
-57%
|
17
+538%
|
19
+13%
|
14
-23%
|
42
+190%
|
72
+73%
|
72
0%
|
222
+207%
|
397
+79%
|
511
+29%
|
|
| Equity | |||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
2
|
8
|
20
|
48
|
77
|
108
|
176
|
279
|
409
|
596
|
836
|
1 123
|
|
| Additional Paid In Capital |
0
|
5
|
67
|
69
|
93
|
109
|
355
|
393
|
425
|
706
|
1 027
|
1 180
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
2
N/A
|
3
-60%
|
46
N/A
|
22
-53%
|
17
-23%
|
1
-95%
|
179
+19 756%
|
114
-36%
|
16
-86%
|
110
+603%
|
191
+74%
|
57
-70%
|
|
| Total Liabilities & Equity |
2
N/A
|
3
+33%
|
49
+1 654%
|
38
-22%
|
36
-7%
|
15
-57%
|
221
+1 332%
|
186
-16%
|
88
-53%
|
332
+278%
|
588
+77%
|
568
-3%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
18
|
11
|
19
|
19
|
26
|
30
|
37
|
37
|
38
|
44
|
47
|
49
|
|
Switch to:
Switch to:
See Also
Discover More
